A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Aveanna Healthcare Holdings, Inc.
AVAH
$2.0B
Mkt Cap
$9.45
+4.07%
Aveanna Healthcare Holdings, Inc. (AVAH) has a current P/E ratio of 25.5.
Aveanna Healthcare Holdings, Inc. (AVAH) has a 5-year average return on invested capital (ROIC) of -4.3%. This is below average and may indicate limited pricing power.
Aveanna Healthcare Holdings, Inc. (AVAH) has a market capitalization of $2.0B. It is classified as a small-cap stock.
Aveanna Healthcare Holdings, Inc. (AVAH) does not currently pay a regular dividend.
Aveanna Healthcare Holdings, Inc. (AVAH) operates in the Services-Home Health Care Services industry, within the Healthcare sector.
Aveanna Healthcare Holdings, Inc. (AVAH) reported annual revenue of $2.4 billion in its most recent fiscal year, based on SEC EDGAR filings.
Aveanna Healthcare Holdings, Inc. (AVAH) has a net profit margin of 9.2%. This is a modest margin.
Aveanna is a Delaware corporation and was incorporated on November 30, 2016, originally under the name BCPE Oasis Holdings Inc. Aveanna commenced operations in March 2017 in connection with the transformative merger of Epic Health Services Inc. and Pediatric Services of America, Inc. in March 2017 under the name BCPE Eagle Holdings Inc. On May 26, 2017, we changed our name to Aveanna Healthcare Holdings Inc. and commenced trading on the Nasdaq Stock Market on April 29, 2021. Our principal executive offices are located at 400 Interstate North Parkway, Suite 1600, Atlanta, Georgia and our phone number is (770) 441-1580. We maintain a website at www.aveanna.com. Information contained on, or accessible through, our website is not a part of and is not incorporated by reference into this Annual Report on Form 10-K.
| Metric | TTM | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 2.3B | 2.4B | 2.0B | 1.9B | 1.8B | 1.5B |
| Net Income | 75M | 225M | -11M | -135M | -662M | -57M |
| EPS | $0.37 | $1.05 | $-0.06 | $-0.71 | $-3.57 | $-0.40 |
| Free Cash Flow | 83M | 126M | 33M | 23M | -64M | 101M |
| ROIC | 10.2% | 19.7% | 7.5% | 0.7% | -49.0% | -0.3% |
| Gross Margin | - | 33.3% | 31.4% | 31.4% | 30.9% | 30.4% |
| Debt/Equity | 0.00 | 6.68 | -10.75 | -10.34 | -213.81 | 4.43 |
| Dividends/Share | $0.00 | $0.00 | - | - | - | - |
| Operating Income | 231M | 256M | 140M | 8.1M | -642M | -3.5M |
| Operating Margin | 10.1% | 10.5% | 6.9% | 0.4% | -35.9% | -0.2% |
| ROE | 821.7% | 115.7% | 8.6% | 198.0% | - | -21.5% |
| Shares Outstanding | 209M | 214M | 182M | 189M | 185M | 143M |
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 1.4B | 1.5B | 1.8B | 1.9B | 2.0B | 2.4B | 2.3B |
| Gross Margin | 30.3% | 30.4% | 30.9% | 31.4% | 31.4% | 33.3% | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 228M | 241M | 357M | 361M | 353M | 374M | 374M |
| EBIT | 39M | -3.5M | -642M | 8.1M | 140M | 256M | 231M |
| Op. Margin | 2.8% | -0.2% | -35.9% | 0.4% | 6.9% | 10.5% | 10.1% |
| Net Income | -77M | -57M | -662M | -135M | -11M | 225M | 75M |
| Net Margin | -5.5% | -3.8% | -37.0% | -7.1% | -0.5% | 9.2% | 3.3% |
| Non-Recurring | -836K | 74M | 675M | 105M | 0 | 1.9M | 1.9M |
| Returns on Capital | |||||||
| ROIC | 12.8% | -0.3% | -49.0% | 0.7% | 7.5% | 19.7% | 10.2% |
| ROE | -24.9% | -21.5% | N/A | 198.0% | 8.6% | 115.7% | 821.7% |
| ROA | N/A | -3.1% | -37.2% | -8.1% | -0.7% | 11.2% | 4.2% |
| Cash Flow | |||||||
| Op. Cash Flow | -8.7M | 117M | -48M | 23M | 33M | 126M | 90M |
| Free Cash Flow | -25M | 101M | -64M | 23M | 33M | 126M | 83M |
| Owner Earnings | -25M | 96M | -86M | -4.3M | 4.4M | 90M | 54M |
| CapEx | 17M | 15M | 16M | 0 | 0 | 0 | 7.0M |
| Maint. CapEx | 14M | 17M | 21M | 14M | 11M | 11M | 11M |
| Growth CapEx | 2.3M | 0 | 0 | N/A | N/A | N/A | 0 |
| D&A | 14M | 17M | 21M | 14M | 11M | 11M | 11M |
| CapEx/OCF | N/A | N/A | N/A | 27.0% | 19.4% | N/A | 7.8% |
| Capital Allocation | |||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | 1.9M | 3.3M | 16M | 13M | 17M | 25M | 25M |
| Debt Repayment | 19M | 46M | 15M | 20M | 2.2M | 3.6M | 3.6M |
| Balance Sheet | |||||||
| Net Debt | 268K | 1.0B | 1.3B | 1.3B | 1.2B | 1.1B | -146M |
| Cash & Equiv. | 3.3M | 137M | 19M | 44M | 84M | 193M | 146M |
| Long-Term Debt | 3.6M | 1.2B | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B |
| Debt/Equity | 0.01 | 4.43 | -213.81 | -10.34 | -10.75 | 6.68 | 0.00 |
| Interest Coverage | 0.4 | -0.0 | -6.0 | 0.1 | 0.9 | 1.8 | 1.8 |
| Equity | 270M | 265M | -6.3M | -130M | -124M | 194M | 9.2M |
| Total Assets | N/A | 1.8B | 1.7B | 1.6B | 1.7B | 2.0B | 1.8B |
| Total Liabilities | 19M | 1.6B | 1.7B | 1.7B | 1.8B | 1.8B | 1.8B |
| Intangibles | N/A | 74M | 96M | 94M | 90M | 93M | 93M |
| Retained Earnings | N/A | -458M | -1.2B | -1.4B | -1.4B | -1.2B | -1.2B |
| Working Capital | N/A | 80M | -57M | -40M | -9.5M | 136M | 136M |
| Current Assets | N/A | 341M | 270M | 315M | 393M | 560M | 560M |
| Current Liabilities | N/A | 260M | 326M | 355M | 402M | 424M | 424M |
| Per Share Data | |||||||
| EPS | -0.56 | -0.40 | -3.57 | -0.71 | -0.06 | 1.05 | 0.37 |
| Owner EPS | -0.18 | 0.68 | -0.46 | -0.02 | 0.02 | 0.42 | 0.26 |
| Book Value | 1.98 | 1.86 | -0.03 | -0.68 | -0.68 | 0.91 | 0.04 |
| Cash Flow/Share | -0.06 | 0.82 | -0.26 | 0.12 | 0.18 | 0.59 | 0.41 |
| Dividends/Share | 0.00 | N/A | N/A | N/A | N/A | 0.00 | 0.00 |
| Shares Out. | 136.6M | 142.6M | 185.4M | 189.5M | 182.2M | 214.3M | 208.9M |
| Valuation | |||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | 25.5 |
| P/FCF | N/A | N/A | N/A | 10.6 | 13.3 | N/A | 23.9 |
| EV/EBIT | N/A | N/A | N/A | 182.5 | 11.6 | N/A | 7.9 |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | 215.0 |
| Price/Sales | N/A | N/A | 0.9 | 0.2 | 0.1 | N/A | 0.9 |
| FCF Yield | N/A | N/A | -6.5% | 9.4% | 7.5% | N/A | 4.2% |
| Market Cap | 0 | N/A | 992M | 241M | 434M | 0 | 2.0B |
| Avg. Price | 0.00 | N/A | 9.06 | 2.47 | 1.58 | 0.00 | 9.45 |
| Year-End Price | 0.00 | N/A | 5.35 | 1.27 | 2.38 | 0.00 | 9.45 |
Aveanna Healthcare Holdings, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 23.9x vs a median of 11.9x. The company's 5-year average gross margin is 31.5%. At current prices, the estimated annualized return to fair value is -6.9%.
Aveanna Healthcare Holdings, Inc. (AVAH) generated $126 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Aveanna Healthcare Holdings, Inc. (AVAH) has a debt-to-equity ratio of 6.68. This indicates higher leverage, which may increase financial risk.
Aveanna Healthcare Holdings, Inc. (AVAH) reported earnings per share (EPS) of $1.05 in its most recent fiscal year.
Aveanna Healthcare Holdings, Inc. (AVAH) has a return on equity (ROE) of 115.7%. This indicates the company generates strong returns for shareholders.
Aveanna Healthcare Holdings, Inc. (AVAH) has a 5-year average gross margin of 31.5%. This indicates decent pricing power.
The Ledger Terminal provides 6 years of financial data for Aveanna Healthcare Holdings, Inc. (AVAH), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Aveanna Healthcare Holdings, Inc. (AVAH) has a book value per share of $0.91, based on its most recent annual SEC filing.